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Edited by Angel NebredaAbstract Among several extracellular messengers tested, lyso-
phosphatidic acid (LPA) was able to cause the most marked
induction of ornithine decarboxylase (ODC) in serum-starved
human T/C-28a2 chondrocytes. LPA also induced the activa-
tion/phosphorylation of Src, Akt and p44/42 MAPK, and the
translocation of PKC-d from cytosol to membrane coupled to
its tyrosine phosphorylation. Experiments with selective signal-
ing inhibitors indicate that LPA leads to Src activation through
Gi protein-coupled receptors. In turn Src can activate PI3K and
PKC-d, and all these signaling proteins are required for ODC
induction. In conclusion these results show that chondrocytes
may be a novel target for LPA action. However, although
LPA is considered a mitogen for several cell types and ODC
induction is generally correlated to cell growth, LPA was not
able to stimulate chondrocyte growth, but rather exerted an
anti-proliferative eﬀect.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Chondrocytes, the only cellular component of articular car-
tilage, diﬀerentiate and proliferate in human beings during the
development, then, for the rest of adult life, they may be re-
garded as terminally diﬀerentiated cells, which are responsible
for the synthesis, metabolic control and integrity of cartilage
extracellular matrix [1]. However, in articular diseases, such
as osteoarthritis, chondrocytes may be diverted from their
homeostasis and undergo cellular alterations such as apopto-
sis, dediﬀerentiation, proliferation, hypertrophy and pheno-Abbreviations: bFGF, ﬁbroblast growth factor-basic; FCS, fetal calf
serum; IGF-I, insulin-like growth factor-I; LPA, lysophosphatidic
acid; LPS, bacterial lipopolysaccharide; MAPK, mitogen-activated
protein kinase; ODC, ornithine decarboxylase; PI3K, phosphatidylin-
ositol 3-kinase; PKC, protein kinase C; PMA, phorbol myristate
acetate; PTH, parathyroid hormone; PTX, pertussis toxin; SPC,
sphingosylphosphorylcholine; SPP, sphingosine-1-phosphate; TGF-
b1, transforming growth factor-b1; TNF, tumor necrosis factor-a
*Corresponding author. Fax: +39 051 2091224.
E-mail address: ﬂavio.ﬂamigni@unibo.it (F. Flamigni).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.04.044type modulation resulting in the synthesis of embryonal-type
matrix components and secretion of matrix degrading en-
zymes. External stimuli, including soluble factors such as cyto-
kines, chemokines and growth factors [2,3] can inﬂuence the
cellular and biochemical functions of chondrocytes, by regulat-
ing signaling pathways and gene expression. However, the
extracellular stimuli and intracellular pathways that can play
a role in various physiological or pathological contexts are
only partially known.
Ornithine decarboxylase (ODC), the ﬁrst and rate-limiting
enzyme of polyamine synthesis [4], is induced in a cell type-spe-
ciﬁc way by a large variety of external stimuli, particularly
those leading to cell growth. ODC and polyamines are well
known to be essential for cell proliferation, but may also be in-
volved in other cellular responses, such as diﬀerentiation and
apoptosis [5]. Although little is known about the function
and regulation of ODC in chondrocytes, some studies have re-
ported high polyamines levels in rheumatoid arthritis [6] and
the eﬀectiveness of ODC inhibitors to avoid experimental
arthritis induced in mouse [7]. Furthermore, we have found
quite recently [8] that ODC inhibition reduces the chondrocyte
response to TNF, a cytokine believed to play a critical role in
arthritis. This background prompted us to investigate possible
extracellular stimuli and signal transduction pathways leading
to the induction of ODC in human T/C-28a2 chondrocytes
[9,10], which have been reported to mimic native articular
chondrocytes in primary culture [11]. We have found in partic-
ular that lysophosphatidic acid (1-oleyl-sn-glycerol 3-phos-
phate, LPA) can induce a marked ODC induction and the
activation of key signaling proteins in these cells, but these
responses do not appear to be related to chondrocyte
proliferation.2. Materials and methods
2.1. Materials
Anti-phospho speciﬁc and total Src antibodies were purchased from
Biosource, whereas an anti phospho-tyrosine antibody, which recog-
nizes general tyrosine-phosphorylated peptides, was obtained from
Cell Signaling Technology/New England Biolabs (p-Tyr-102, cat.
#9416, Lot.1). Anti-phospho speciﬁc (Thr202/Tyr204) and total p44/
42 MAPK, anti-phospho speciﬁc (Ser473) and total Akt were also
from New England Biolabs, anti-PKC-d from Santa Cruz and anti-
Ki-67 from Oncogene. Bacterial lipopolysaccharide (LPS), ATP,
sphingosylphosphorylcholine (SPC), LPA, sphingosine-1-phosphate
(SPP), phorbol myristate acetate (PMA), isoproterenol, parathyroid
hormone (PTH) and pertussis toxin (PTX) were obtained from Sigma.blished by Elsevier B.V. All rights reserved.
Fig. 1. Eﬀect of various extracellular stimuli on the induction of ODC
activity in T/C-28a2 chondrocytes. Conﬂuent, serum-starved T/C-28a2
chondrocytes were treated with the indicated compounds. After 4 h
cells were harvested and assayed for ODC activity. Concentrations of
compounds in cell medium was as follows: fetal calf serum, 10%; TNF,
500 U/ml; LPS, 10 lg/ml; ATP, 100 lM; histamine, 10 lM; SPC,
10 lM; LPA, 10 lM; SPP, 10 lM; isoproterenol, 10 lM; GTE, 50 lM;
SDF-1, 100 nM; TGF-b1, 10 ng/ml; PTH, 100 nM; IGF-I, 10 nM;
bFGF, 5 ng/ml. Data are means ± S.E.M.
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from Alexis. Tumor necrosis factor-a (TNF) and transforming growth
factor-b1 (TGF-b1) were from Cabru, human recombinant insulin-like
growth factor-I (IGF-I) and ﬁbroblast growth factor-basic (bFGF)
from Peprotech; green tea extract (GTE) was from Indena and hista-
mine from RBI. DMEM, fetal calf serum (FCS), antibiotics and L-glu-
tamine were purchased from Cambrex S.r.L.
2.2. Cell culture and treatment
The immortalized human juvenile costal chondrocytes, T/C-28a2
[9,10], have been used extensively as a reproducible ‘‘in vitro’’ model
to study a variety of chondrocyte responses in experiments requiring
large numbers of cells. T/C-28a2 chondrocytes were grown in DMEM
with 10% FCS, 2 mM L-glutamine and antibiotics (100 U/ml penicillin,
100 lg/ml streptomycin). For experiments conﬂuent cells were kept in
a serum-free medium for 24 h before treatment with LPA or other
compounds. All the inhibitors were added 30 min before LPA, except
PTX (4 h before). These compounds were added in dimethylsulfoxide
(except PTX solubilized in water). Control cells received equal
amounts of the vehicle. LPA was solubilized in a solution
CHCl3:CH3OH (2:1) and then frozen in aliquots at 20 C. Each ali-
quot was exsiccated under nitrogen and the pellet was resuspended in
the same volume of PBS-BSA (0.4%, fatty acid free). This solution was
stable for 24 h. Each experiment was repeated at least twice. Graphs
refer to experiments with at least duplicate samples and immunoblots
show one representative result.
2.3. Determination of ODC activity
Cell extracts were prepared and assayed for ODC activity as previ-
ously described [12]. ODC activity is expressed as units/mg protein,
where 1 unit corresponds to 1 nmol of CO2/h incubation.
2.4. Immunoprecipitation and detection of phosphorylated PKC-d
Cells were treated with LPA for the time indicated and then harvested
in lysis buﬀer containing 20 mMHEPES, 2 mM EDTA, 0.1% CHAPS,
0.1% Triton X-100, 5 mMDTT, 1 mMPMSF, 1 lg/ll of aprotinin, leu-
peptin and pepstatin, 1 mM Na3VO4, 1 mM benzamidine, 10 mM
PNPP, 10 mM b-glycerophosphate. Aliquots corresponding to 500 lg
proteins (in the case of Fig. 5B) or 200 lg proteins (in the case of Fig.
5C) were incubated with antibody against PKC-d for 2 h at 4 C and
then with protein A–Sepharose for a further 1 h. The immunocomplex
was centrifuged, washed three times with lysis buﬀer and dissolved in
Laemmli buﬀer. Immunoprecipitated proteins were separated in 10%
SDS–PAGE, transferred on to nitrocellulose membrane. The mem-
brane was saturated with 5% non-fat milk and probed with anti phos-
pho-tyrosine antibody overnight at 4 C. Immunoreactivity was
detected with the ECL system and, in the case of the experiment shown
in Fig 5C, quantiﬁed by intensitometric software QScan from Biosoft.
2.5. Western blotting for p60 Src, Akt, Ki-67 and p44/42 MAPK
Cells were incubated and harvested as described before. As for p60
Src, Akt and Ki-67, aliquots of 80 lg proteins were separated by SDS–
PAGE and transferred on to nitrocellulose membrane. The membrane
was saturated with 5% non-fat milk and then probed with speciﬁc anti-
bodies overnight at 4 C (90 min at R.T. in the case of Ki-67). Bands
were revealed by the Amersham ECL detection system. Western blot-
ting for p44/42 MAPK was performed as described [13].
2.6. Subcellular fractionation and detection of PKC-d
Cells were incubated and harvested with lysis buﬀer containing
250 mM sucrose, 2 mM EGTA, 1 mM EDTA, 1 mM PMSF, 20 mM
HEPES. Homogenisation with 45 strokes was carried out at 4 C.
Homogenates were centrifuged for 10 min at 500g at 4 C and the
resulting supernatant was centrifuged for 30 min at 110000g. The
resulting pellet was resuspended in the same buﬀer containing 1% Tri-
ton X-100 and protease inhibitors (leupeptin, pepstatin, and aprotinin)
and centrifuged for 50 min at 110000g. The supernatant (Triton X-100
soluble membrane fraction) was stored at 80 C. 50 lg proteins of
cytosol and membrane fraction were dissolved in Laemmli buﬀer, sep-
arated by 10% SDS–PAGE and transferred onto nitrocellulose mem-
brane. The membrane was saturated with 5% non-fat milk and then
incubated with anti PKC-d antibody. Bands were revealed by the
Amersham ECL detection system.2.7. Cell proliferation assay
Cells were seeded at low density (5000 cells/well) in microtiter plates.
After 1 day cells were shifted to a serum-free medium and treated with
LPA or serum. The number of cells was evaluated by the cell prolifer-
ation kit I (MTT) obtained from Boehringer–Mannheim. This colori-
metric assay is based on the cleavage of the yellow tetrazolium salt
MTT to purple formazan crystals by metabolic active cells and was
carried out according to Manufacturers instructions. Cell viability
was evaluated by Trypan blue exclusion, and expressed as the percent-
age of viable cells (excluding the dye) with respect to the total number
of cells. In some experiments (Fig. 6B), the number of cells was evalu-
ated by means of the PicoGreen dsDNA quantitation reagent (Molec-
ular Probes, Eugene, OR), constructing a calibration curve with
known number of chondrocytes, as detailed elsewhere [8]. Caspase
activity was also assayed as described in [8].3. Results
3.1. Eﬀect of various extracellular stimuli on ODC activity in T/
C-28a2 chondrocytes
In order to identify some possible agents able to induce
ODC activity in chondrocytes, we tested a large number of
extracellular stimuli. Most of these stimuli may play a role in
chondrocyte biology or have been found to induce ODC in
other cell types [14–16]. Apart from 10% fetal calf serum, a
universal and strong ODC inducer, IGF-I, which may promote
both proliferation and diﬀerentiation of chondrocytes [17], and
LPA, which in contrast has no reported role in chondrocyte
biology, were able to cause a substantial induction of ODC
activity (Fig. 1). In particular, LPA, a ligand of speciﬁc G pro-
tein-coupled receptors [18–20], provoked an increase by about
10-fold on average. Other lysophospholipids that may act as
extracellular messengers, i.e. SPC and SPP, and TNF, which
can favour apoptosis in chondrocytes [21], caused a more mod-
est increase. Finally, other messengers, including PTH, TGF-b,
stromal cell-derived factor-1 (SDF-1) and bFGF were ineﬀec-
tive in these cells. Thus the study was focused on LPA eﬀects.
The time-course and dose-dependence of ODC activity are
shown in Fig. 2. After an initial lag period, ODC activity in-
Fig. 3. Eﬀect of LPA on p44/42 MAPK (A) and of signaling inhibitors
on ODC induction (B). (A) Conﬂuent, serum-starved cells were
incubated with 10 lM LPA for the time indicated and then analysed
for active, phosphorylated p44/42 MAPK by Western blotting. The
membrane was then stripped and re-probed with a total anti-p44/42
MAPK antibody. In a distinct experiment (right), PD 98059 was also
added before LPA to check its eﬀectiveness in inhibiting MAPK
activation. (B) Conﬂuent, serum-starved cells were treated with the
indicated inhibitors 30 min (4 h in the case of PTX) before treatment
with 10 lMLPA or 100 ng/ml PMA. After 4 h cells were harvested and
assayed for ODC activity. Data are means ± S.E.M.
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of 10 lMLPA, then the enzyme activity declined and was close
to the control value after 16 h (Fig. 2A). The dose-eﬀect graph
shows that the induction of ODC activity was markedly in-
creased at 10 lM LPA and remained elevated even at 20 lM,
but decreased using a higher concentration of the compound
(Fig. 2B).
3.2. Eﬀect of inhibitors of key signaling proteins on ODC
induction
We have assessed the relevance of key signaling proteins in
LPA-stimulated chondrocytes, such as Gi proteins, p60 Src
tyrosine kinase, protein kinase C-d (PKC-d), p44/42 mitogen-
activated protein kinase (MAPK) and phosphoinositide 3-ki-
nase (PI3K) by using selective inhibitors. The eﬀects of PTX
(Gi protein inhibitor), PP1 (p60 Src tyrosine kinase inhibitor),
rottlerin (PKC-d inhibitor), LY 294002 (PI3K inhibitor) and
PD 98059 (p44/42 MAPK pathway inhibitor) on ODC induc-
tion are shown in Fig. 3. Although p44/42 MAPK activation
has been reported to be involved in ODC induction provoked
by various agents in several cell types [13–16,22] and LPA
actually caused an increase in the amount of active/phosphor-
ylated MAPK in T/C-28a2 cells (Fig. 3A), experiments with
the speciﬁc inhibitor PD 98059 indicated that this kinase is
not required for ODC induction by LPA in these cells (Fig.
3B). U0126, another selective and even more potent inhibitor
of the MAPK pathway, could not prevent the ODC increase
either (not shown). Instead, PTX was able to cause a dramatic
reduction of the induction of ODC activity in our experimental
model, suggesting that Gi proteins are involved in the signalFig. 2. Time course and dose-dependence of ODC induction by LPA
in T/C-28a2 cells. (A) Eﬀect of LPA on the time-course of ODC
activity. 10 lM LPA was administered to conﬂuent, serum-starved
cells. At the time indicated cells were harvested and assayed for ODC
activity. (B) Eﬀect of increasing concentration of LPA on ODC
activity. Conﬂuent, serum-starved cells were treated with LPA at the
indicated concentration, harvested after 4 h and assayed for ODC
activity. Data are means ± S.E.M.transduction pathway leading to the induction of ODC activ-
ity. Also PP1, LY 294002 and rottlerin were eﬀective to inhibit
the induction of ODC activity, suggesting the involvement of
p60 Src tyrosine kinase, PI3K and PKC-d, respectively.
PKC-d, like any other ‘‘novel’’ PKC isoform, does not depend
on intracellular Ca2+ levels, but can be activated by phorbol
esters, such as PMA. Thus the involvement of PKC-d was also
suggested by the lack of eﬀect of BAPTA/AM, an intracellular
Ca2+ chelator, together with the ODC inducing eﬀect of PMA,
which was likewise prevented by rottlerin (Fig. 3B).
3.3. Eﬀect of LPA on Src and Akt activation
The previous experiments with PP1 prompted us to investi-
gate whether LPA was able to activate Src. Src has a complex
mechanism of activation, which comprises the autophosphory-
lation of a speciﬁc tyrosine residue (Tyr416) and the dephos-
phorylation of another one [23]. In our experimental
conditions we found that LPA increased the phosphorylation
of Src at Tyr416 within 5 min of treatment (Fig. 4A). It has
been reported that in certain conditions the complete activa-
tion of Src also requires the dephosphorylation of Tyr527
[23]. However this dephosphorylation is not always needed
[24] and in our conditions, LPA did not reduce the phosphor-
ylation of Tyr527 (data not shown). We tested the eﬀect of the
inhibitors, which were previously shown to be eﬀective in
reducing ODC activity. PP1 was used as a positive control.
PTX reduced the increase in the phosphorylation of Src, in
accordance with many studies that indicate that Gi proteins
are involved in the signal transduction of LPA from the mem-
brane receptor to Src [18]. Although it has been reported by
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conditions, LY 294002 was unable to modify the phosphoryla-
tion state of Src, suggesting that PI3K may rather lay down-
stream of Src or on a separate pathway. Rottlerin was not
able to reduce the enhanced phosphorylation of Src by LPA
either, indicating that PKC-d is not required for this phosphor-
ylation. To understand if PI3K lies downstream of Src or on a
separate pathway, we evaluated the eﬀect of the Src inhibitor,
PP1, on the activation state of a typical substrate of PI3K, Akt
(Fig. 4B). LPA was able to activate Akt by increasing its phos-
phorylation in a PI3K-dependent manner as shown by the sen-
sitivity to LY 294002. PP1 abolished this activation indicating
that Src is upstream of PI3K, as described in other experimen-
tal systems [23,25].
3.4. Eﬀect of LPA on PKC-d activation
Since the previous experiments suggested the involvement of
PKC-d in the action of LPA, we tested the eﬀect of LPA on the
activation of this protein and investigated if PKC-d lays down-
stream Src in our experimental model. The translocation from
cytosol to the membrane is a well-established mechanism of
activation of PKC-d [26–29]. Phosphorylation of PKC-d on
tyrosine residues can be a further mechanism of modulation
of the enzyme, often resulting in an increase in its kinase activ-
ity, depending on cellular type and substrate involved [26–30].
In chondrocytes, LPA induced both the translocation and theFig. 4. LPA activates Src and Akt kinases in T/C-28a2 cells. (A) LPA
induces the activation of p60 Src kinase by increasing the phosphor-
ylation of a speciﬁc tyrosine residue (Tyr416). Conﬂuent, serum-
starved cells were incubated with the indicated inhibitors 30 min before
the addition of 10 lM LPA (4 h in the case of PTX). After 5 min cells
were harvested and cell extracts were analyzed by Western blotting by
using a phospho-speciﬁc Src (Tyr416) antibody. The membrane was
stripped and re-probed with a total anti-Src antibody. (B) LPA induces
the activation of Akt in T/C-28a2 cells, by increasing its phosphor-
ylation. Conﬂuent, serum-starved cells were incubated with 10 lM
LPA for 5 min and with the indicated inhibitors 30 min before the
addition of LPA. Cells were harvested and cell extracts were analyzed
by Western blotting by using a phospho-speciﬁc Akt (Ser473)
antibody. The membrane was stripped and re-probed with a total
anti-Akt antibody.
Fig. 5. LPA activates PKC-d in T/C-28a2 cells. (A) LPA induces the
translocation of PKC-d from cytosol to membrane. Conﬂuent, serum-
starved cells were treated with 10 lM LPA. After 5 min cells were
harvested and subcellular fractions were analyzed by Western blotting
using a speciﬁc anti PKC-d antibody. (B) LPA induces tyrosine
phosphorylation of PKC-d. Conﬂuent, serum-starved cells were
incubated with 10 lM LPA. After 5 min cells were harvested and cell
extracts immunoprecipitated with anti-PKC-d antibody. The immu-
nocomplexes were analyzed by Western blotting by using a general
phospho-tyrosine antibody. The membrane was stripped and re-
probed with an anti-PKC-d antibody. (C) Various signaling inhibitors
prevent the LPA-induced tyrosine phosphorylation of PKC-d. Con-
ﬂuent, serum-starved T/C-28a2 cells, were incubated with the indicated
inhibitors 30 min before the addition of 10 lM LPA (4 h in the case of
PTX). PKC-d tyrosine phosphorylation was detected as described in
the legend of Fig. 5B, except for the lesser starting material used for
immunoprecipitation (see Section 2), which accounts for the weaker
intensity of the bands of Fig. 5C compared to Fig. 5B. The membrane
was stripped and re-probed with an anti PKC-d antibody resulting in
minimal diﬀerences among bands (not shown). Quantiﬁcation by
densitometry of phospho-Tyr PKC-d normalized for total PKC-d is
shown at the bottom.phosphorylation of PKC-d (Fig. 5A and B), suggesting that
even in our experimental model PKC-d tyrosine phosphoryla-
tion is coupled to an activation of the enzyme. We also tested
the eﬀect of the signaling inhibitors on the phosphorylation
status of PKC-d (Fig. 5C). All the compounds (LY 294002,
PP1, Rottlerin and PTX) were eﬀective in reducing the phos-
Fig. 6. Eﬀect of LPA and serum on Ki-67 expression and cell proliferation and viability. (A, B) Conﬂuent, serum-starved cells were incubated with
10 lMLPA or 10% serum. Ki-67 level (A) was determined in cell extracts by Western blotting after 20 h incubation. Cell number (B) was determined
by DNA quantitation after 2 and 3 days of incubation. Data are means ± S.E.M., N = 3. \P < 0.05 vs. control by unpaired t test. (C, D) Non-
conﬂuent cell cultures were incubated with 10 lM LPA or 10% serum as described in Section 2. Cell proliferation (C) and cell viability (D) were
evaluated by the MTT assay and by the Trypan blue test, respectively, at the time indicated after LPA or serum. Data are means ± S.E.M. (N = 3 for
C and N = 4 for D).
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PI3K, Src and Gi proteins lay upstream of PKC-d. Several
studies suggest that Src may be the kinase responsible of
PKC-d phosphorylation [26–30], but PI3K may also be re-
quired somehow for this phosphorylation, as judged by the
sensitivity to LY 294002. In this regard it has been reported
that PKC-d activation was dependent on PI3K in RIF tumor
cells exposed to hypoxia [31].
3.5. Eﬀect of LPA on the proliferation of T/C-28a2 chondrocytes
Since LPA is considered to be a mitogen for several cell types
[18] and ODC induction is generally correlated to cell growth
[4,5], we have investigated whether LPA was able to stimulate
the proliferation of T/C-28a2 chondrocytes. As a proliferation
marker, we evaluated the expression of the nuclear Ki-67 pro-
tein by Western blotting. In fact, Ki-67 is expressed in prolif-
erating, but not in quiescent human cells, and is widely used
to determine the proportion of proliferating cells in human cell
populations [32]. Fig. 6A shows that Ki-67 content was re-
duced after 20 h of treatment with LPA, and this eﬀect was
prevented by PTX. On the contrary 10% serum, used as a po-
sitive control, provoked an increase in Ki-67 expression. DNA
quantitation indicated that the number of chondrocytes was
signiﬁcantly reduced after 2 and 3 days of LPA treatment with
respect to control (by 26% and 27%, respectively, Fig. 6B). It
should be noted that the previous experiments were performed
with conﬂuent cell cultures, so growth curves were obtained
starting from non-conﬂuent cultures to evaluate more carefully
the LPA eﬀect on chondrocyte proliferation (Fig. 6C). LPAcould not mimic the action of serum on cell proliferation: un-
like serum, incubation of chondrocytes with LPA did not in-
crease the number of chondrocytes, which was actually
reduced with respect to control (P < 0.05 by paired t-test). In
fact, the number of LPA-treated cells, evaluated by the MTT
test, was about 20, 50 and 40% of control after 1, 2 and 3 days
of treatment, respectively. This reduction in cell number was
substantially conﬁrmed by directly counting of the cells, result-
ing 51 ± 6.7% of control after 1 day (mean ± SEM, N = 4,
P < 0.05 by unpaired t-test). Besides, the reduction in cell num-
ber was not due to a decrease in cell viability (Fig. 6D), ruling
out an apoptotic or cytotoxic eﬀect of LPA. Accordingly, the
induction of eﬀector caspase activity, critical enzymes in the
executive phase of apoptosis, was not observed after LPA
treatment (not shown). These results indicate that LPA is
not a mitogen for human T/C-28a2 chondrocytes, but rather
exerted an antiproliferative eﬀect.4. Discussion
LPA is a bioactive phospholipid present in serum (2–20 lM)
bound to albumin [18]. Although all cells contain small
amounts of LPA associated with membrane biosynthesis,
LPA can be released by some cellular sources such as activated
platelets, leukocytes, epithelial cells, neuronal cells and tumor
cells. LPA is a potent signaling molecule able to provoke a
variety of cellular responses in many cell types, including cell
proliferation and diﬀerentiation [18–20]. The biological actions
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receptors, which activate various downstream signaling path-
ways through at least three diﬀerent types of heterotrimeric
G proteins [18,19]. However, the mechanisms of activation
of the key proteins involved in LPA-triggered pathways and
their reciprocal interactions are scarcely deﬁned.
The present paper shows that physiological concentrations
of LPA are able to activate key signaling pathways in human
chondrocytes involving Gi proteins, p60 Src tyrosine kinase,
PKC-d, p44/42 MAPK and PI3K and to induce ODC mark-
edly. Therefore, chondrocytes may be a novel target for LPA
action. This study also represents the ﬁrst report that LPA
can induce ODC in mammalian cells. Experiments with selec-
tive inhibitors together with available data in the literature
indicate that LPA leads to Src activation through speciﬁc Gi
protein-coupled receptors. Src then can activate PI3K and
PKC-d. All these signaling proteins are required for ODC
induction. Although fragmentary data are available about
the involvement of some of these proteins in ODC expression
in diﬀerent cells [13,22,33,34], the possible pathway(s) and
interrelations of these proteins had not been reported previ-
ously. Regarding PKC-d, it has been shown that LPA can in-
duce nuclear localization of PKC-d in bovine theca cells [35].
Furthermore, PKC-d is known to regulate gene expression
through various mechanisms [36] and in particular it can be re-
quired for ODC induction in papilloma PE cells exposed to
oxidative stress [33]. Interestingly, we have found a rottlerin-
sensitive increase in ODC mRNA level following LPA treat-
ment, as determined by RT-PCR (not shown).
These results raise the question of a possible function of
LPA in chondrocytes. Although ODC induction is generally
correlated to cell growth and polyamines are required for cell
proliferation, LPA was not a mitogen for human T/C-28a2
chondrocytes. Rather it appeared to exert an anti-proliferative
eﬀect. Interestingly, some reports indicate that ODC and poly-
amines are good markers of diﬀerentiated chondrocytes
[37,38]. Therefore, further studies will be carried out to inves-
tigate whether LPA may favour chondrocyte diﬀerentiation.
Another worthwhile pursuit suggested by our ﬁndings would
be to ascertain whether LPA concentration and chondrocyte
response might vary in cartilage under various physiological
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